By Genetic Engineering and Biotechnology News –
Improving the cultivation of large bioprinted tissues could help make laboratory-grown tissue models more reliable for drug development and regenerative medicine. At the International Society for Cell & Gene Therapy (ISCT) 2026 annual meeting in Dublin, Elliot Cowles, a doctoral student in bioprocess engineering at Université Claude Bernard Lyon 1, and colleagues presented a perfusion-based culture system, which was described in Cytotherapy, that addresses this challenge. Although biofabricated tissues are increasingly used for in vitro research, many remain relatively small and are typically grown under static conditions that limit scalability and consistency.
